Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002072 · ClinicalTrials.gov registry record · NA
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
A NA study, sponsored by Ortho Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
NCT00002072: Completed NA study, sponsored by Ortho Pharmaceuticals.
NCT00002072 is a NA study that has completed, run by Ortho Pharmaceuticals. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002072, a NA study, has completed, sponsored by Ortho Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To determine the safety and efficacy of erythropoietin (r-HUEPO) administered to AIDS patients with anemia secondary to their disease and/or concomitant zidovudine (AZT) therapy.
Interventions
- DRUG Epoetin alfa
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002072 record still lists
NCT00002072 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Epoetin alfa is the first listed.
NCT00002072 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002072 about?
NCT00002072 is a clinical study titled "A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy". To determine the safety and efficacy of erythropoietin (r-HUEPO) administered to AIDS patients with anemia secondary to their disease and/or concomitant zidovudine (AZT) therapy.
What is the current status of trial NCT00002072?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002072?
The interventions under investigation include: Epoetin alfa (DRUG).
Who is sponsoring clinical trial NCT00002072?
This trial is sponsored by Ortho Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.